Market Report, "Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013", Published
Global Markets Direct's, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diffuse Large B-Cell Lymphoma. Diffuse Large B-Cell Lymphoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release